Skip to main content

Cases

Lorem ipsum dolor sit amet, sed do eiusmod tempor incididunt et dolore magna aliqua.

Cyrano Therapeutics and Resyca announce exclusive license agreement for soft mist nasal spray technology for the treatment of persistent smell loss

28 January, 2025

Resyca receives medical device regulation certificate from TÜV SÜD

Silo Pharma and Resyca BV partner on device and CMC development for intranasal PTSD drug SPC-15